|
ZCCHC11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.85007606193722E-14 |
| Normal-vs-Stage2 |
7.70900010493847E-10 |
| Normal-vs-Stage3 |
1.17461596005342E-13 |
| Normal-vs-Stage4 |
3.49239526187262E-11 |
| Stage1-vs-Stage2 |
2.345600E-01 |
| Stage1-vs-Stage3 |
7.295700E-02 |
| Stage1-vs-Stage4 |
1.967180E-01 |
| Stage2-vs-Stage3 |
8.955600E-01 |
| Stage2-vs-Stage4 |
9.695400E-01 |
| Stage3-vs-Stage4 |
9.218800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.782100E-03 |
| Normal-vs-Asian |
1.59940000132863E-08 |
| Caucasian-vs-AfricanAmerican |
1.020340E-02 |
| Caucasian-vs-Asian |
7.157200E-01 |
| AfricanAmerican-vs-Asian |
5.714300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.66373598126302E-15 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
3.582200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.42594833110843E-12 |
| Normal-vs-Age(41-60Yrs) |
1.14341869306145E-12 |
| Normal-vs-Age(61-80Yrs) |
1.91080484768236E-12 |
| Normal-vs-Age(81-100Yrs) |
5.407600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.494800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.333800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.638400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.792300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.633800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.162200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.846600E-04 |
| Classical-VS-Follicular |
5.801900E-02 |
| Classical-VS-Other |
4.181400E-01 |
| Classical-VS-Normal |
3.40700001544292E-09 |
| Tall-VS-Follicular |
2.371200E-01 |
| Tall-VS-Other |
5.284400E-01 |
| Tall-VS-Normal |
3.65263375101677E-12 |
| Follicular-VS-Other |
9.656800E-01 |
| Follicular-VS-Normal |
8.70169492017681E-11 |
| Other-VS-Normal |
2.155600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.99680288865056E-15 |
| Normal-vs-N1 |
1.99859995220208E-09 |
| N0-vs-N1 |
9.786200E-01 |
|
|
